Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05083559 · ClinicalTrials.gov registry record · NA

Two Way Crossover Closed Loop Study R-AP vs MPC

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT05083559 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05083559, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. The robust R-AP system used in this protocol has been designed to handle a variety of real-world scenarios that are critical to a high-risk patient population. The investigators will test how well the new algorithm handles missed or inaccurate meal announcements. This type of algorithm may significantly improve glucose control over the standard model predictive control (MPC) closed-loop algorithm without these new algorithm features for patients with type 1 diabetes.

Interventions

  • DEVICE MPC AP algorithm
  • DEVICE Robust R-AP algorithm

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-12-08
Est. Completion 2022-03-03
Phase NA

What the Registry Record Tells You About NCT05083559

The ClinicalTrials.gov registry entry for NCT05083559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which MPC AP algorithm is the first listed.

NCT05083559 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05083559 about?

NCT05083559 is a clinical study titled "Two Way Crossover Closed Loop Study R-AP vs MPC". An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. The robust R-AP system used in this protocol has been designed to handle a variety of real-world scenarios t...

What is the current status of trial NCT05083559?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-12-08. Estimated completion is 2022-03-03.

What interventions are being tested in trial NCT05083559?

The interventions under investigation include: MPC AP algorithm (DEVICE), Robust R-AP algorithm (DEVICE).

Who is sponsoring clinical trial NCT05083559?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.